...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats
【24h】

Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats

机译:莫索尼定和胍丁胺对自发性高血压大鼠心脏交感神经抑制作用的药理分析

获取原文
获取原文并翻译 | 示例

摘要

This study shows that in spontaneously hypertensive rats (SHR) of 14-weeks-old, the sympathetically induced, but not noradrenaline-induced tachycardic response are higher than age-matched Wistar normotensive rats. Furthermore, in SHR the sympathetically-induced tachycardic response was: (1) unaffected by moxonidine (3 mu g/kg min); (2) partially inhibited by B-HT 933 (30 mu g/kg min), both at the lowest doses; and (3) completely inhibited by the highest doses of B-HT 933 (100 mu g/kg min), moxonidine (10 mu g/kg min) or agmatine (1000 and 3000 mu g/kg min) while the noradrenaline-induced tachycardic responses remained unaffected by the above compounds, except by 3000 mu g/kg min agmatine. In SHR, 300 mu g/kg rauwolscine failed to block the sympatho-inhibition to 100 mu g/kg min B-HT 933 or 10 mu g/kg min moxonidine, but 1000 mu g/kg rauwolscine abolished, partially antagonized, and did not modify the sympatho-inhibition to the highest doses of B-HT 933, moxonidine, and agmatine, respectively, 3000 mu g/kg AGN 192403 or 300 mu g/kg BU224 given alone had no effect in the moxonidine- or agmatine-induced sympatho-inhibition, and the combination rauwolscine plus AGN 192403 but not plus BU224, abolished the sympatho-inhibition to the highest doses of moxonidine and agmatine. In conclusion, the sympathetically-induced tachycardic responses in SHR are inhibited by moxonidine and agmatine. The inhibition of moxonidine is mainly mediated by prejunctional alpha(2)-adrenoceptors and to a lesser extent by I-1-imidazoline receptors, while the inhibition of agmatine is mediated by prejunctional alpha(2)-adrenoceptors and I-1-imidazoline receptors at the same extent. Notwithstanding, the inhibitory function of alpha(2)-adrenoceptors seems to be altered in SHR compared with Wistar normotensive rats. (C) 2016 Elsevier B.V. All rights reserved.
机译:这项研究表明,在14周龄的自发性高血压大鼠(SHR)中,交感神经诱导的,但不是去甲肾上腺素引起的心动过速反应高于年龄匹配的Wistar血压正常的大鼠。此外,在SHR中,交感神经引起的心动过速反应为:(1)不受莫索尼定(3μg / kg min)的影响; (2)在最低剂量下均被B-HT 933(30μg/ kg min)部分抑制; (3)最高剂量的B-HT 933(100μg / kg min),莫索尼定(10μg/ kg min)或胍丁胺(1000和3000μg/ kg min)完全抑制,而去甲肾上腺素诱导除了3000μg / kg的最小胍丁胺外,心动过速反应不受上述化合物的影响。在SHR中,300μg / kg的狼疮素未能阻止对100μg / kg的B-HT 933或10μg / kg的最小莫索尼定的交感抑制作用,但1000μg / kg的狼疮素被废除,部分拮抗并发生了抑制作用不能将交感抑制分别改变为最高剂量的B-HT 933,莫索尼定和胍丁胺,单独给予3000μg / kg AGN 192403或300μg/ kg BU224对莫索尼定或胍丁胺诱导的无效交感神经抑制作用,以及劳沃素+ AGN 192403但不联合BU224的组合,取消了对最大剂量的莫索尼定和胍丁胺的交感神经抑制作用。总之,莫索尼定和胍丁胺抑制了SHR中交感神经引起的心动过速反应。莫索尼定的抑制作用主要由结前α(2)-肾上腺素受体介导,程度较小的则由I-1-咪唑啉受体介导,而胍丁胺的抑制作用由结前α(2)-肾上腺素受体和I-1-咪唑啉受体介导。在同一程度上。尽管如此,与Wistar血压正常的大鼠相比,SHR中的α(2)-肾上腺素受体的抑制功能似乎有所改变。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号